Desflurane 1000 MG/ML Inhalation Solution [Suprane] — RxCUI 208919
RxNorm drug concept · Semantic branded drug
RxCUI 208919
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI208919
Official nameDesflurane 1000 MG/ML Inhalation Solution [Suprane]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSuprane 100 % Inhalation Solution; Suprane 1 ML/ML Inhalation Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)727 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Desflurane: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Desflurane is a general anesthetic — a gas you breathe in through a mask or breathing tube that puts you into a controlled state of unconsciousness so you don't feel anything durin...
- What exactly is desflurane and why is my doctor using it for my surgery?
- The most common things people notice after surgery with desflurane are nausea and vomiting — about 1 in 4 patients experience this. You may also have a mild sore throat or a headac...
- What side effects should I expect when I wake up?
🕸️ Concept Web — How Desflurane 1000 MG/ML Inhalation Solution [Supra... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Desflurane 1000 MG/ML Inhalation Solution [Suprane]
RxCUI 208919 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Desflurane
27340IN
-
Desflurane
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Suprane
152394BN
-
Suprane
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Desflurane Inhalation Solution
2108330SCDF -
Desflurane Inhalant Product
1157752SCDG -
Desflurane Inhalation Solution [Suprane]
2108333SBDF -
Suprane Inhalant Product
1184866SBDG -
Inhalation Solution
346161DF -
Inhalant Product
1151123DFG
-
Desflurane Inhalation Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Desflurane 1000 MG/ML Inhalation Solution
562366SCD -
Desflurane 1000 MG/ML
2108329SCDC -
Desflurane 1000 MG/ML [Suprane]
2108332SBDC
-
Desflurane 1000 MG/ML Inhalation Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Desflurane 1000 MG/ML Inhalation Solution
SCD · 562366 -
Desflurane 1000 MG/ML
SCDC · 2108329 -
Desflurane Inhalation Solution
SCDF · 2108330 -
Desflurane Inhalant Product
SCDG · 1157752
Brand-Name Concepts
-
Desflurane 1000 MG/ML [Suprane]
SBDC · 2108332 -
Desflurane Inhalation Solution [Suprane]
SBDF · 2108333 -
Suprane Inhalant Product
SBDG · 1184866 -
Suprane
BN · 152394
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 208919 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00404-9961-25 | 1 BOTTLE in 1 BAG (0404-9961-25) / 240 mL in 1 BOTTLE | Suprane | Henry Schein, Inc. | 2022-01-12 |
| 10019-0641-34 | 6 BOTTLE in 1 CARTON (10019-641-34) / 240 mL in 1 BOTTLE (1... | SUPRANE | Baxter Healthcare Corporation | 1992-09-18 |
| 10019-0644-34 | 6 BOTTLE in 1 CARTON (10019-644-34) / 240 mL in 1 BOTTLE (1... | Suprane | Baxter Healthcare Corporation | 1992-09-18 |
| 10019-0646-34 | 6 BOTTLE in 1 CARTON (10019-646-34) / 240 mL in 1 BOTTLE (1... | SUPRANE | Baxter Healthcare Corporation | 1992-09-18 |
Observed labelers:
Baxter Healthcare Corporation (3) ·
Henry Schein, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.